Cargando…

Effect of rs67085638 in long non‐coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA‐24‐3p and FSCN1

It has been reported that rs67085638 in long non‐coding RNAs (lncRNA)‐CCAT1 was associated with the risk of tumorigenesis. Also, CCAT1 could affect chemoresistance of cancer cells to paclitaxel (PTX) via regulating miR‐24‐3p and FSCN1 expression. In this study, we aimed to investigate the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zhong‐Sheng, Zhao, Lei, Zhang, Xiao‐Ning, Li, Han‐Xian, Yin, Zhi‐Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051717/ https://www.ncbi.nlm.nih.gov/pubmed/33709519 http://dx.doi.org/10.1111/jcmm.16210

Ejemplares similares

Long noncoding RNA CCAT1 rs67085638 SNP contribution to the progression of gastric cancer in a Polish population
por: Olesiński, Tomasz, et al.
Publicado: (2021)

Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1
por: Li, Xiaohui, et al.
Publicado: (2020)

LncRNA PRNCR1 rs1456315 and CCAT2 rs6983267 Polymorphisms on 8q24 Associated with Lung Cancer
por: Yu, Wei-Ling, et al.
Publicado: (2021)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
por: Wang, De-Ying, et al.
Publicado: (2020)

Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016)

CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer
por: Liau, Xiew Leng, et al.
Publicado: (2023)

Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis
por: Thean, Lai Fun, et al.
Publicado: (2021)

The role of microRNA-133b and its target gene FSCN1 in gastric cancer
por: Guo, Lihua, et al.
Publicado: (2014)

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2018)

Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
por: Yang, Chun, et al.
Publicado: (2019)

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
por: Zhang, Caixiang, et al.
Publicado: (2019)

Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion
por: Chen, Jia-jia, et al.
Publicado: (2015)

Correction to: The role of microRNA-133b and its target gene FSCN1 in gastric cancer
por: Guo, Lihua, et al.
Publicado: (2020)

Long non-coding RNA ENST00000500843 is downregulated and promotes chemoresistance to paclitaxel in lung adenocarcinoma
por: Tian, Xin, et al.
Publicado: (2019)

Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
por: Shan, Liping, et al.
Publicado: (2020)

Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancer
por: Yu, Yue, et al.
Publicado: (2023)

Long non-coding RNA CCAT1 enhances human non-small cell lung cancer growth through downregulation of microRNA-218
por: Zhao, Lijiang, et al.
Publicado: (2020)

LncRNA CCAT1 is overexpressed in tuberculosis patients and predicts their survival
por: Ye, Taosheng, et al.
Publicado: (2021)

LncRNA PTOV1-AS2 Promotes Colon Cancer Progression through the miR-145-5p/FSCN1 Axis
por: Zhang, Zhen, et al.
Publicado: (2023)

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
por: Ling, Hui, et al.
Publicado: (2013)

Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155
por: Dou, Lidong, et al.
Publicado: (2017)

Correction: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma
por: Shan, Liping, et al.
Publicado: (2023)

Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach
por: Mizrahi, Ido, et al.
Publicado: (2015)

Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis
por: Wu, Le, et al.
Publicado: (2016)

Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells
por: Guo, Hua, et al.
Publicado: (2016)

Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p
por: Ma, M-Z, et al.
Publicado: (2015)

Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia
por: Chen, Lianxiang, et al.
Publicado: (2016)

MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1
por: Li, Ying-Qing, et al.
Publicado: (2015)

Long non-coding RNA CCAT1 promotes colorectal cancer cell migration, invasiveness and viability by upregulating VEGF via negative modulation of microRNA-218
por: Gu, Chao, et al.
Publicado: (2020)

Significance of BMI1 and FSCN1 Expression in Colorectal Cancer
por: Alajez, Nehad M.
Publicado: (2016)

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
por: Barros-Silva, Daniela, et al.
Publicado: (2020)

Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis
por: Zhang, Zhihui, et al.
Publicado: (2018)

Expression of Concern: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
Publicado: (2023)

lncRNA CCAT1 Acts as a MicroRNA-218 Sponge to Increase Gefitinib Resistance in NSCLC by Targeting HOXA1
por: Jin, Xiang, et al.
Publicado: (2020)

The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis
por: Huang, Shuying, et al.
Publicado: (2016)

Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer
por: Wang, Dalu, et al.
Publicado: (2021)

CCAT: Combinatorial Code Analysis Tool for transcriptional regulation
por: Jiang, Peng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4ecr80t6ur9ejd307kef7n1o8f